News archives


OCTOBER - DECEMBER 17

JULY - SEPTEMBER 17

APRIL - JUNE 17

JANUARY - MARCH 17

OCTOBER - DECEMBER 16

JULY - SEPTEMBER 16

APRIL - JUNE 16

JANUARY - MARCH 16

OCTOBER - DECEMBER 15

JULY - SEPTEMBER 15

APRIL - JUNE 15

JANUARY - MARCH 15

OCTOBER - DECEMBER 14

JULY - SEPTEMBER 14

APRIL - JUNE 14

JANUARY - MARCH 14

OCTOBER - DECEMBER 13

JULY - SEPTEMBER 13

APRIL - JUNE 13

JANUARY - MARCH 13

OCTOBER - DECEMBER 12

JULY - SEPTEMBER 12

APRIL - JUNE 12

JANUARY - MARCH 12

OCTOBER - DECEMBER 11

JULY - SEPTEMBER 11

APRIL - JUNE 11

JANUARY - MARCH 11

OCTOBER - DECEMBER 10

JULY - SEPTEMBER 10

APRIL - JUNE 10

JANUARY - MARCH 10

OCTOBER - DECEMBER 09

JULY - SEPTEMBER 09

APRIL - JUNE 09

JANUARY - MARCH 09

OCTOBER - DECEMBER 08

JULY - SEPTEMBER 08

APRIL - JUNE 08

JANUARY - MARCH 08

OCTOBER - DECEMBER 07

JULY - SEPTEMBER 07

APRIL - JUNE 07

JANUARY - MARCH 07

 
  current news   Press   selected story    
     
  20th October  
  The IQGAP Iqg1 is a regulatory target of CDK for cytokinesis in Candida albicans
 
 




Authors
CR Li, YM Wang, Y Wang

Abstract
Cyclin-dependent kinases (CDKs) drive and coordinate multiple cell-cycle events, including construction and contraction of the actomyosin ring during cytokinesis. However, it remains unclear whether CDKs regulate cytokinesis by directly targeting components of the ring. In a search for proteins containing consensus CDK phosphorylation sites in Candida albicans, we found that the IQGAP Iqg1 contains two dense clusters of 19 such sites flanking the actin-interacting CH domain. Here, we show that Iqg1 is indeed a phosphoprotein that undergoes cell-cycle-dependent phosphorylation and can be phosphorylated by purified ClbCdc28 kinases in vitro. Mass spectrometry identified several phosphoserine and phosphothreonine residues among these CDK sites. Mutating 15 of the CDK phosphorylation sites with alanine markedly reduced Iqg1 phosphorylation in vivo. The 15A mutation greatly stabilized Iqg1, caused both premature assembly and delayed disassembly of the actomyosin ring, blocked Iqg1 interaction with the actin-nucleating proteins Bni1 and Bnr1, and resulted in defects in cytokinesis. Our data therefore strongly support the idea that the Cdc28 CDK regulates cytokinesis partly by directly phosphorylating the actomyosin ring component Iqg1.


Figure Legend: The 15A mutation stabilizes Iqg1 and affects the dynamics of the actomyosin ring. (A) Log-phase cells expressing WT Iqg1 (LCR26), Iqg1-15A (LCR29) or Iqg1-15E (LCR32) as the sole source of Iqg1 were arrested with 30 M nocodazole for 2 hr and then stained with rhodamine-phalloidine to reveal the actin ring at the neck and with 4',6-diamidino-2-phenylindole (DAPI) to visualize nuclei. (B) The nocodazole-arrested cells described in (A) were released into drug-free medium for growth at 30C. Cells were harvested at intervals for actin and nuclear staining. Percentage of cells with a neck actin ring and with divided nuclei was counted. (C) Stationary cells expressing WT Iqg1 (LCR26), Iqg1-15A (LCR29) or Iqg1-15E (LCR32) were released into fresh YPD for growth at 30C. Aliquots were harvested at 0, 1, 2, and 3 hr and lysates were prepared for Western blotting using Myc Ab (all Iqg1 proteins have a 6Myc tag). Duplicate blots were probed with PSTAIRE Ab to detect Cdc28 as loading controls. (D) Cell lysates prepared as described in (B) and analyzed by Western blotting using Myc Ab and PSTAIRE Ab.

The EMBO Journal advance online publication 16 October 2008;
doi: 10.1038/emboj.2008.219
.

For more information on A/Prof. Wang Yues lab, Please Click here.